SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-007770
Filing Date
2015-02-11
Accepted
2015-02-11 12:58:23
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v400442_10k.htm 10-K 1048665
2 EXHIBIT 23.1 v400442_ex23-1.htm EX-23.1 2774
3 EXHIBIT 31.1 v400442_ex31-1.htm EX-31.1 8452
4 EXHIBIT 31.2 v400442_ex31-2.htm EX-31.2 8287
5 EXHIBIT 32 v400442_ex32.htm EX-32 3997
6 GRAPHIC tpg1.jpg GRAPHIC 6022
  Complete submission text file 0001144204-15-007770.txt   7165943

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cltx-20141231.xml EX-101.INS 1134852
8 XBRL TAXONOMY EXTENSION SCHEMA cltx-20141231.xsd EX-101.SCH 51355
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cltx-20141231_cal.xml EX-101.CAL 28574
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cltx-20141231_def.xml EX-101.DEF 244338
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cltx-20141231_lab.xml EX-101.LAB 320937
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cltx-20141231_pre.xml EX-101.PRE 291656
Mailing Address C/O MARK COHEN, CHAIRMAN, PEARL COHEN 1500 BROADWAY, 12TH FLOOR NEW YORK NY 10036
Business Address 53 DAVIES STREET LONDON X0 W1K 5JH 646-878-0804
Celsus Therapeutics Plc. (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 10-K | Act: 34 | File No.: 001-36288 | Film No.: 15598251
SIC: 2834 Pharmaceutical Preparations